Central Nervous System Therapeutic Market 2030: From 130.1 to 254.6 Billion Dollars
Central Nervous System Therapeutics Market Summary The global central nervous system (CNS) therapeutics market was valued at USD 130.1 billion in 2024 and is expected to reach USD 254.6 billion by 2030, expanding at a CAGR of 7.7% from 2025 to 2030. This growth is strongly influenced by the rapid expansion of the aging population. According to the World Health Organization, the number of people aged 60 years and above is projected to reach 2.1 billion by 2050, driving a notable rise in CNS disorders. Conditions such as Alzheimer’s and Parkinson’s are increasingly prevalent among older adults, generating significant demand for effective therapeutic solutions and creating substantial opportunities across the healthcare and pharmaceutical sectors. Beyond demographic changes, the growing incidence of multiple sclerosis (MS) further fuels market expansion. Recent data from the National Multiple Sclerosis Society indicates that 2.9 million people worldwide are living with MS, w...